Results 181 to 190 of about 151,327 (305)
Molecular alterations in high-grade neuroendocrine tumors of the small intestine. [PDF]
Hercent A +9 more
europepmc +1 more source
Editorial: Optimizing the first-line treatment for metastatic colorectal cancer
Davide Ciardiello, Angelica Petrillo
doaj +1 more source
Molecular reprogramming in thymic neuroendocrine tumors: a narrative review. [PDF]
Di J, Zhou Y, Hu J.
europepmc +1 more source
Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to ...
Lara R. S. Fonseca +6 more
wiley +1 more source
Defining endoscopic candidacy for intermediate size rectal neuroendocrine tumors. [PDF]
Sheng YH +4 more
europepmc +1 more source
Monogenic and syndromic obesity in children often arises from defects in the leptin–melanocortin pathway. Understanding these rare genetic causes not only clarifies mechanisms of appetite regulation but also enables precision therapies, offering hope beyond lifestyle interventions.
Hadel Khalil +2 more
wiley +1 more source
Children with cancer received more palliative care consultation before, but fewer during, critical illness compared with adults. This disparity suggests underuse of palliative care during pediatric critical care. ABSTRACT Importance Palliative care consultation is an essential component of comprehensive care for patients with cancer during critical ...
Conrad Krawiec, Neal Thomas
wiley +1 more source
Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1. [PDF]
Kozlov SV +9 more
europepmc +1 more source
ABSTRACT Background The management of intermediate‐risk early prostate cancer (PCa) is challenging due to the difficulty in distinguishing indolent from aggressive tumors. This study explores the association between genomic alterations and the tumor and its microenvironment (TME) and implications for disease progression. Methods We performed multi‐omic
William Lautert‐Dutra +13 more
wiley +1 more source
Challenges in the management of bone metastases: focus on differentiated thyroid cancer and neuroendocrine tumors. [PDF]
Chen J, Wu JY.
europepmc +1 more source

